Glioma and Exercising
Influence of Physical Activity in Patients With High Grade Glioma (WHO III° and IV°) on Patients' Psychological Well Being, Sleep and Quality of Life
1 other identifier
interventional
39
1 country
2
Brief Summary
To investigate the influence of two physical activity and exercising (PAE) interventions, namely resistance training and endurance training in relation to quality of life, depression, fatigue, sleep, anxiety, stress and coping, body image, and social interactions (psychological dimensions); cardiorespiratory fitness, morning cortisol secretion, inflammatory markers, and objective sleep (physiological dimensions), along with cancer-related dimensions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 26, 2018
CompletedFirst Submitted
Initial submission to the registry
December 4, 2018
CompletedFirst Posted
Study publicly available on registry
December 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedMay 18, 2022
May 1, 2022
3.3 years
December 4, 2018
May 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Change in Functional Assessment of Cancer Therapy Scale (FACT)
Cancer-related Quality of Life (QOL) assessed by Functional Assessment of Cancer Therapy Scale (FACT), a self-report instrument which measures multidimensional QOL. The FACT evaluation system uses a 29-49 item compilation of a generic core and numerous subscales (9-20 items each) which reflect symptoms associated with different diseases, symptom complexes and treatments.
Baseline and week 3 and week 6
Change in Hamilton Depression Rating Scale (HDRS)
HDRS scale to assess patients' severity of Depression (mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms); each item on the questionnaire is scored on a 3 or 5 point scale; a score of 0-7 is considered to be normal
Baseline and week 3 and week 6
Change in Intolerance of Uncertainty Scale (IU)
IU: 5-point rating scale (1 = not at all characteristic of me, 5 = entirely characteristic of me) indicating how much patient agrees with the item. The higher the overall score is, the more the respondent is assumed to be more intolerant of uncertainty
Baseline and week 3 and week 6
Change in Insomnia Severity Index (ISI)
ISI is a 7-item screening measure for insomnia. Items answered on 5-point rating scales (0 = not at all, 4 = very much)
Baseline and week 3 and week 6
Change in Perceived Stress Scale (PSS)
General perceived stress is assessed with the 10-item Perceived Stress Scale (PSS). The PSS measures the degree to which respondents find their lives unpredictable, uncontrollable and overloading. Answers were given on a five-point Likert-type scale anchored at 1 (never) to 5 (very often). Four items were reverse scored. The mean was calculated in order to obtain an overall score.
Baseline and week 3 and week 6
Change in Fatigue Severity Scale
nine items, and answers are given on seven-point rating scales ranging from 1 (not at all) to 7 (definitively/almost always), with higher mean scores reflecting greater fatigue
Baseline and week 3 and week 6
Change in Mental Toughness Questionnaire (MTQ48)
The 48 item MTQ48 measures the subcomponents challenge, commitment, emotional and life control, and interpersonal confidence and confidence in ability. Answers are given on five-point Likert-type scales ranging from 1 (=strongly disagree) to 5 (=strongly agree), with higher scores reflecting greater MT
Baseline and week 3 and week 6
Change in International Physical Activity Questionnaire
questionnaire consists of several items and asks about the amount of days with walking, moderate and vigorous physical activity.
Baseline and week 3 and week 6
Change in submaximal 6-min walking test (6MWT)
To assess functional exercise capacity, distance walked during 6 min will be assessed and compared to reference age and gender norms
Baseline and week 3 and week 6
Change in Grip force
Maximum isometric grip force of the dominant hand is assessed using the hand dynamometer. Participants make three attempts. Mean outcomes is compared to reference data
Baseline and week 3 and week 6
Secondary Outcomes (3)
Change in sleep continuity assessed by EEG
Baseline and week 6
Change in C reactive protein (CRP) (mg/l)
Baseline and week 6
Change in sleep architecture (min; %)
Baseline and week 6
Study Arms (3)
Endurance training
ACTIVE COMPARATOREndurance Training (warm-up; endurance on bike; brisk walking; cooling down; group sessions; supervised; moderate and individualized exercising load): 6 weeks, 2 sessions/week, 40-60min/session
Resistance training
ACTIVE COMPARATORResistance Training (warm-up; resistance training units; cooling down; group sessions; supervised; moderate and individualized exercising load): 6 weeks, 2 sessions/week, 40-60min/session
Control condition
ACTIVE COMPARATORControl condition (individualized counselling, but not intended as a bona fide intervention, that is to say: not intended to actively improve participants' well-being): 6 weeks, social support and counseling,1-2 sessions/week; 30 min/session
Interventions
Eligibility Criteria
You may qualify if:
- Patients with high grade glioma (WHO III° and IV°), and undergoing radiotherapy, chemotherapy, or both
- Willing and able to follow the study intervention
- Signed written informed consent
You may not qualify if:
- Severe psychiatric (psychosis, suicidal behavior, substance use disorder) and somatic comorbidities (severe cardiovascular disease, severe diabetes, impairments of the musculo-skeletal system)
- patients not willing or able anymore to follow the study protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University Hospital Basel, Department of Neurosurgery
Basel, 4031, Switzerland
Department of Sport, Exercise and Health, University of Basel
Basel, 4052, Switzerland
Related Publications (1)
Cordier D, Gerber M, Brand S. Effects of two types of exercise training on psychological well-being, sleep, quality of life and physical fitness in patients with high-grade glioma (WHO III and IV): study protocol for a randomized controlled trial. Cancer Commun (Lond). 2019 Aug 9;39(1):46. doi: 10.1186/s40880-019-0390-8.
PMID: 31399142DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Serge Brand, PD Dr. phil
Department of Sport, Exercise, and Health, University of Basel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2018
First Posted
December 13, 2018
Study Start
October 26, 2018
Primary Completion
February 28, 2022
Study Completion
February 28, 2022
Last Updated
May 18, 2022
Record last verified: 2022-05